SC
Solas Capital Management, LLC cut its FENC stake below 5%
Solas Capital Management, LLC reported owning 4.1% of Fennec Pharmaceuticals Inc. (FENC) (1,433,282 shares) in a Schedule 13G filed Nov 16, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 16, 2026
- Source
- Schedule 13G